Építés alatt – nem éles oldal
Belépés
VisszavonvaNo phase

Effectiveness of an Online Self-management Intervention for Type 2 Diabetes Mellitus

Megadott ok: No participants could be recruited.

Key facts

Where
Hamburg, NémetországSee the site

Where in Németország

  • GAIAHamburg, NémetországNo longer taking part

Trial details

Who runs it
Gaia AG
Trial code
NCT05525117
Record updated
2024. május 28.
Original description
This trial was designed to evaluate the effectiveness of the dialogue-based online intervention covivio, which was designed to improve diabetes self-management in patients with type 2 diabetes.Read full original descriptionShow less

Evaluating the Effectiveness of an Online Self-management Intervention for Type 2 Diabetes Mellitus (Covivio): Randomized Controlled Trial

This trial was designed to evaluate the effectiveness of the dialogue-based online intervention covivio, which was designed to improve diabetes self-management in patients with type 2 diabetes.

The study aims to test the hypothesis that covivio has a greater positive impact on glycemic control than treatment as usual. Patients with type 2 diabetes mellitus will be randomized and allocated to either an intervention group, receiving covivio in addition to treatment as usual, or a control group, which receives only treatment as usual. The primary endpoint is the HbA1c value six month after baseline.

Inclusion: diagnosis of T2DM (submission of a medical certificate attesting to the presence of at least one of the following ICD-10-GM diagnoses of T2DM: E11.20, E11.30, E11.40, E11.50, E11.60, E11.72, E11.74, E11.80, E11.90); HbA1c value ≥ 7.0% (53 mmol/mol); BMI ≥ 23 kg/m2; Consent to participate; Sufficient knowledge of the German language.

Exclusion: change in medication, frequency of use or dosage (planned within 4 weeks before T0 or during the study period); diagnosis of type 1 diabetes mellitus (T1DM).

ClinicalTrials.gov NCT05525117

Építés alatt, nem éles – Effectiveness of an Online Self-management Intervention for Type 2 Diabetes Mellitus (NCT05525117) – Frontlight Research